このページは機械翻訳されています。他のページは英語で表示される場合があります。View in English
GOREISANは,ICAT-β-カテニン/ERK軸の調節により,HFD/L-NAMEによって誘発された保存されたエジェクション分数による心不全における心筋縮および腹動機能障害を緩和する.
Yoko Shojima Isayama1,2, Shouji Matsushima3,4, Keisuke Shinohara1,2
1Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
PubMed で要約を見る
まとめ
Goreisan (GRS) は,心筋縮と腹動機能不全を軽減することによって,心筋縮を保存した心筋縮 (HFpEF) を効果的に治療します. この薬草は,ICAT-β-カテニン/ERK経路を標的とし,潜在的な治療の選択肢を提供します.
科学分野:
- 心血管研究
- 薬理学について
- 中国 伝統 医学
背景:
- 保存されたエジェクション分数 (HFpEF) による心不全は,心筋縮と腹筋機能不全によって特徴づけられる世界的な健康上の懸念事項です.
- ゴレーサン (Goreisan,GRS) のような伝統的なハーブ製薬は,心臓血管疾患における治療の可能性について調査されています.
研究 の 目的:
- 保存されたエジェクション分数 (HFpEF) の心不全の病理生理学的改善におけるGoreisan (GRS) の有効性を調査する.
- GRSが心筋縮と腹動機能不全に及ぼす影響の分子メカニズムを解明する.
主な方法:
- HFpEFのマウスモデルは,高脂肪食 (HFD) とN-ニトロ-L-アルギニンメチレスター (L-NAME) を使用して確立されました.
- 心臓と肺の重量,心室壁の厚さ,腹動機能指数 (E/ A,E/ E'),および心筋細胞のサイズに対するGRS治療の効果を評価した.
- 分子分析には,ミトゲン活性化タンパク質キナーゼ (MAPK) のためのウエスタン・ブロッティングと,タンパク質プロファイルのための液体染色体/質量スペクトロメトリー (LC-MS) が含まれていた.
- GRSの直接的作用とICAT,β-カテニン,ERKの役割を調べるために,インビトロ試験では,イソプロテレノール (ISO) 治療を受けた心筋細胞を使用した.
主要な成果:
関連する概念動画
01:29Heart Failure II: Pathophysiology
37
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
37
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
01:22Heart Failure Drugs: Diuretics
483
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
483
01:17Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
01:30Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
01:22Mitral Stenosis I: Introduction
34
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
34